Literature DB >> 29082467

Let-7d microRNA Attenuates 6-OHDA-Induced Injury by Targeting Caspase-3 in MN9D Cells.

Li Li1, Hui Liu2, Haijing Song3, Yingsong Qin2, Ying Wang2, Ming Xu2, Chaoxia Liu2, Jin Gao4, Shen Sun5.   

Abstract

Parkinson's disease (PD) mainly results from the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc), and the exact underlying mechanisms of the loss of DA neurons in PD remains largely unclear. The results of our previous work showed that let-7d was significantly downregulated in a 6-OHDA-induced cellular model of PD. However, the exact effect of let-7d on DA neural cells was unclear. In MN9D dopaminergic neuronal cells, we used a let-7d mimic and inhibitor to upregulate and downregulate the expression of let-7d, respectively, a cell counting kit to assess cell viability, and a TUNEL staining assay and flow cytometry to examine the cell death rate, and we found that let-7d could negatively regulate 6-OHDA-induced cell injury. Then, we verified that caspase-3 was a target gene of let-7d by using a dual-luciferase reporter system. Furthermore, using caspase-3 siRNA and a caspase-3-overexpression vector (without the 3'UTR) to respectively inhibit and increase the expression of caspase-3, we found that caspase-3 siRNA could reverse the cell injury induced by the let-7d inhibitor and that caspase-3 overexpression could reverse the protective effects of the let-7d mimic on 6-OHDA-induced cell injury. Taken together, these findings strongly suggest that let-7d plays an important role in DA neuronal cell injury and that the effects of let-7d are, at least in part, via the suppression of caspase-3 expression.

Entities:  

Keywords:  6-OHDA; MN9D cells; Parkinson’s disease (PD); microRNA-let-7d

Mesh:

Substances:

Year:  2017        PMID: 29082467     DOI: 10.1007/s12031-017-0994-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

1.  Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis.

Authors:  Stephan Persengiev; Ivanela Kondova; Nel Otting; Arnulf H Koeppen; Ronald E Bontrop
Journal:  Neurobiol Aging       Date:  2010-05-06       Impact factor: 4.673

Review 2.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 3.  Fine-tuning neural gene expression with microRNAs.

Authors:  Gerhard Schratt
Journal:  Curr Opin Neurobiol       Date:  2009-06-17       Impact factor: 6.627

Review 4.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

5.  MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.

Authors:  Haihai Liang; Xuelian Li; Lu Wang; Shaonan Yu; Zhidan Xu; Yunyan Gu; Zhenwei Pan; Tianyu Li; Meiyu Hu; Hairong Cui; Xue Liu; Ying Zhang; Chaoqian Xu; Rui Guo; Yanjie Lu; Baofeng Yang; Hongli Shan
Journal:  Cell Physiol Biochem       Date:  2013-12-16

Review 6.  Does neuronal loss in Parkinson's disease involve programmed cell death?

Authors:  J K Andersen
Journal:  Bioessays       Date:  2001-07       Impact factor: 4.345

7.  Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples.

Authors:  Gerard J Nuovo; Michela Garofalo; Nicola Valeri; Vicki Roulstone; Stefano Volinia; David E Cohn; Mitch Phelps; Kevin J Harrington; Richard Vile; Alan Melcher; Evanthia Galanis; Sarah Sehl; Rob Adair; Karen Scott; Ailsa Rose; Giles Toogood; Matthew C Coffey
Journal:  Mod Pathol       Date:  2012-06-15       Impact factor: 7.842

8.  Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.

Authors:  Yun Min Ding; Juliann D Jaumotte; Armando P Signore; Michael J Zigmond
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

Review 9.  Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

Authors:  Maria C Rodriguez-Oroz; Marjan Jahanshahi; Paul Krack; Irene Litvan; Raúl Macias; Erwan Bezard; José A Obeso
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

Review 10.  Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?

Authors:  V Bogaerts; J Theuns; C van Broeckhoven
Journal:  Genes Brain Behav       Date:  2007-08-03       Impact factor: 3.449

View more
  6 in total

Review 1.  Parkinson's disease and microRNAs - Lessons from model organisms and human studies.

Authors:  Brian Evans; Howard A Furlong; Alexandre de Lencastre
Journal:  Exp Gerontol       Date:  2021-10-08       Impact factor: 4.032

2.  Comparison of Rat Primary Midbrain Neurons Cultured in DMEM/F12 and Neurobasal Mediums.

Authors:  Neda Valian; Mansooreh Heravi; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Basic Clin Neurosci       Date:  2021-03-01

Review 3.  Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.

Authors:  Hantao Zhang; Xiaoyan Liu; Yi Liu; Junlin Liu; Xun Gong; Gang Li; Min Tang
Journal:  Front Aging Neurosci       Date:  2022-08-09       Impact factor: 5.702

4.  Chronic delta-9-tetrahydrocannabinol (THC) treatment counteracts SIV-induced modulation of proinflammatory microRNA cargo in basal ganglia-derived extracellular vesicles.

Authors:  Hussein Kaddour; Marina McDew-White; Miguel M Madeira; Malik A Tranquille; Stella E Tsirka; Mahesh Mohan; Chioma M Okeoma
Journal:  J Neuroinflammation       Date:  2022-09-12       Impact factor: 9.587

Review 5.  Role of MicroRNAs in Parkinson's Disease.

Authors:  Suh Yee Goh; Yin Xia Chao; Shaikali Thameem Dheen; Eng-King Tan; Samuel Sam-Wah Tay
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

Review 6.  Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.

Authors:  Shubhra Acharya; Antonio Salgado-Somoza; Francesca Maria Stefanizzi; Andrew I Lumley; Lu Zhang; Enrico Glaab; Patrick May; Yvan Devaux
Journal:  Int J Mol Sci       Date:  2020-09-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.